Checkpoint Inhibitor Pneumonitis With Pneumomediastinum Following Nivolumab-AVD in Classic Hodgkin Lymphoma: A Case Report
{{output}}
Background: Immune checkpoint inhibitors have transformed cancer treatment but may cause pulmonary immune-related toxicities even after therapy completion. Observ... ...
